Tracking cancer drugs in living cells by thermal profiling of the proteome
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitski et al. take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects. Science , this issue 10.1126/science.1255784
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thermal proteome profiling (TPP, Savitski et al, 2014) is a mass-spectrometry (MS) based functional proteomics method that can identify shifts in protein thermal stability across different conditions (Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Especially in combination with quantitative changes measured by e.g., phosphoproteomics, TPP can be used to identify functionally relevant alterations and link them to signaling and phenotypic consequences (Savitski et al, 2014; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“TPP has been used successfully in the past for drug profiling, but it generates complex data that are difficult to interpret and potentially benefit from integration with other data types (Savitski et al, 2014; Perrin et al, 2020; Mateus et al, 2020).”
From Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition (2024) · cites this paper as Savitski et al, 2014
In the citing paper
“Thermal stabilization (i) is leveraged in thermal proteomics profiling (TPP), an approach that has been employed to, for instance, identify the ferrochelatase FECH as a frequent off-target of kinase inhibitors,224 or to uncover leucine aminopeptidase 3 as an off-target of several HDAC inhibitors.225”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [224]
In the citing paper
“This assay is based on the concept that binding of a compound to a protein can result in thermal stabilization of the protein and-consequently-in a detectable shift of its melting curve.”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Savitski et al., 2014
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Self-citationDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P. N., Cho, H., Spevak, W., Zhang, C., Zhang, Y., Habets, G., et al. (2010) · Nature · doi:10.1038/nature09454 · Cited by 1,831
Mass-spectrometry-based draft of the human proteome
Wilhelm, M., Schlegl, J., Hahne, H., Gholami, A. M., Lieberenz, M., Savitski, M. M., Ziegler, E., Butzmann, L., Gessulat, S., Marx, H., et al. (2014) · Nature · doi:10.1038/nature13319 · Cited by 1,820
Self-citationOverriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., & Mann, M. (2014) · Nature Methods · doi:10.1038/nmeth.2834 · Cited by 1,719
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Self-citation
Cited by
Items 901–1,000 of 1,004
Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates
Rogawski, R., Rogel, A., Bloch, I., Gal, M., Horovitz, A., London, N., & Sharon, M. (2021) · Angewandte Chemie · doi:10.1002/ange.202104947 · Cited by 3
Saei, A. A., Gharibi, H., Lyu, H., Nilsson, B., Jafari, M. T., von Holst, H., & Zubarev, R. A. (2023) · Molecules · doi:10.3390/molecules28196768 · Cited by 2
Engineering cell-free systems by chemoproteomic-assisted phenotypic screening
Levitskaya, Z., Ser, Z., Koh, H. W. L., Mei, W. S., Chee, S. M. Q., Sobota, R. M., & Ghadessy, F. J. (2024) · RSC Chemical Biology · doi:10.1039/d4cb00004h · Cited by 2
Gualdrini, F., Rizzieri, S., Polletti, S., Pileri, F., Zhan, Y., Cuomo, A., & Natoli, G. (2024) · Molecular Systems Biology · doi:10.1038/s44320-024-00040-x · Cited by 4
“Other techniques that measure selectivity pro fi les in a more physiological setting include assays based on the effects of small molecule binding on the thermal stability of their targets in cells or cell lysates (Savitski et al, 2014).”
Polyphenol Tannin‐Induced Protein Precipitation for Drug Target Discovery by Chemical Proteomics
Gao, Y., Zhang, X., Ye, M., & Hu, L. (2024) · ChemistrySelect · doi:10.1002/slct.202404735 · Cited by 2
Phenomics‐Based Discovery of Novel Orthosteric Choline Kinase Inhibitors
Bauer, L. G., Ward, J., Saez, L. D., Sundström, Y., Tolvanen, T. A., Barrera, J. C. A., Kostidis, S., Rogers, C. M., Panagakou, I., Singh, U., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202420149 · Cited by 2
Ying, G., He, Y., Yang, M., Lü, G., Li, Y., Cui, W., Hu, Z., & Zhang, Z. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04857 · Cited by 2
Tian, X., Mueller, P., Sosnowski, P., Li, F., Guan, D., Jacquet, C., & Gérard Hopfgartner, D. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00051 · Cited by 2
MSstatsTMT Improves Accuracy of Thermal Proteome Profiling
Figueroa‐Navedo, A. M., Kapre, R., Gupta, T., Xu, Y., Phaneuf, C. G., Beltran, P. M. J., Xue, L., Ivanov, A. R., & Vitek, O. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.100999 · Cited by 4
ECBS & ICBS 2015 Joint Meeting: Bringing Chemistry to Life
Silva, D. V. (2015) · ChemBioChem · doi:10.1002/cbic.201500684 · Cited by 2
Cell Density Affects the Detection of Chk1 Target Engagement by the Selective Inhibitor V158411
Geneste, C. C., & Massey, A. J. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217738534 · Cited by 2
Unexpected cause of vemurafenib-induced nephrotoxicity: ferrochelatase
Yamada, R., & Yanagita, M. (2021) · Kidney International · doi:10.1016/j.kint.2021.09.010 · Cited by 2
Zhou, L., Wang, Z., Wen, S., Li, J., Xiong, L., & Zhu, Z. (2021) · Ibrain · doi:10.1002/j.2769-2795.2021.tb00064.x · Cited by 2
Chakraborty, S., Kannihalli, A., Mohanty, A., & Ray, S. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0003 · Cited by 2
Wang, X., Chen, C., He, Y., Ding, L., Wu, Y., Huang, C., Wu, J., Ding, R., Xue, Y., Lin, Z., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202303656 · Cited by 2
Herbst, S. A., & White, F. M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100483 · Cited by 2
Courouble, V. V., Mann, M. D., & Griffin, P. R. (2023) · Israel Journal of Chemistry · doi:10.1002/ijch.202300084 · Cited by 2
New approaches to antibacterial drug discovery
Turan, N. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00008-4 · Cited by 3
Thermal proteome profiling efficiently identifies ribosome destabilizing oxazolidinones
Nöcker, C., Kaiser, N., Foley, D. J., Sievers, S., Janning, P., Waldmann, H., & Laraia, L. (2021) · Tetrahedron · doi:10.1016/j.tet.2021.132118 · Cited by 2
Structural and functional studies of proteins in cell signaling and cancer
Dovega, R. (2014) · Figshare · Cited by 2
Self-citationPanov, A., & Gygi, S. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/751818 · Cited by 2
“(B) Correlation matrix as in (A), except after applying the global normalization scheme from Savitski et al. (2014).”
MethodInfluentialUsmanova, D. R., Plata, G., & Vitkup, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/736280 · Cited by 3
A MALDI-TOF assay identifies nilotinib as an inhibitor of inflammation in acute myeloid leukaemiaPreprint
Marín-Rubio, J. L., Heap, R. E., Heunis, T., Dueñas, M. E., Inns, J., Scott, J., Simpson, A. J., Blair, H., Heidenreich, O. T., Allan, J. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.29.437557 · Cited by 2
Khusainov, I. S., Romanov, N., Goemans, C., Turoňová, B., Zimmerli, C. E., Welsch, S., Langer, J. D., Typas, A., & Beck, M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.06.546847 · Cited by 2
“This method quantifies changes in protein abundance, thermal stability, and solubility, thereby creating a holistic overview of the proteome state and revealing potential off-target effects (Savitski et al., 2014).”
MethodMerging Multi-OMICs with Proteome Integral Solubility Alteration Unveils Antibiotic Mode of ActionPreprint
Maity, R., Zhang, X., Liberati, F. R., Rossi, C. S., Cutruzzolà, F., Rinaldo, S., Gaetani, M., Aínsa, J. A., & Sancho, J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.07.556692 · Cited by 2
“…pre-defined target flavodoxin, it is paramount to mention that some targets exhibit very limited shifts in solubility changes upon drug binding ( Molina et al., 2013 ; Sabatier et al., 2022 ; Savitski et al., 2014 ), making the detection of the target difficult at a statistically significant level.”
BackgroundPotel, C. M., Burtscher, M. L., Garrido‐Rodríguez, M., Brauer-Nikonow, A., Becher, I., Typas, A., Zimmermann, M., & Savitski, M. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.13.557529 · Cited by 3
“, 2014) which can inform on changes in ligand binding properties (Savitski et al., 2014) as well as protein interactions (Tan et al.”
InfluentialSelf-citationsCIP-ing towards streamlined chemoproteomicsPreprint
Burton, N. R., & Backus, K. M. (2023) · ChemRxiv · doi:10.26434/chemrxiv-2023-0szhj · Cited by 2
Do light eaters live shorter lives? The case of ultralight Caenorhabditis elegansPreprint
Zhang, X., Gharibi, H., Beusch, C. M., Meng, Z., Saei, A. A., Gaetani, M., & Zubarev, R. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.13.580069 · Cited by 2
“The protein melting curves were fitted with the equation and the middle point provides the melting temperature Tm: where the term B is responsible for the slope steepness (lower values mean steeper curve) and Pl is the high-temperature plateau of the melting curve 33, 34 .”
MethodSubcellular thermal profiling enables the deep functional exploration of the mitochondrial proteomePreprint
Rivera-Mejías, P., Sueur, C. L., Kurzawa, N., Becher, I., & Savitski, M. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582308 · Cited by 2
“Thermal proteome profiling (TPP) 12 measures the system-wide thermal stability of proteins by combining multiplexed mass spectrometry (MS)-based quantitative proteomics 13,14 with the principle of the cellular thermal shift assay 15,16 .”
BackgroundMethodSelf-citationThe Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2Preprint
Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., Stevens, M. G., et al. (2025) · eLife · doi:10.7554/elife.103484.1 · Cited by 5
Elsässer, F., Florea, R., Räsch, F., Weis, K., de Souza, N., & Picotti, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.21.639445 · Cited by 2
McCracken, N. A., Justice, S. A. P., Smith-Kinnaman, W. R., Wijeratne, H. R. S., Runnebohm, A. M., Pelletier, S. W., Doud, E. H., Wek, R. C., & Mosley, A. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.08.647882 · Cited by 2
The Mac1 ADP-ribosylhydrolase is a Therapeutic Target for SARS-CoV-2Preprint
Suryawanshi, R. K., Jaishankar, P., Correy, G. J., Rachman, M. M., O’Leary, P. C., Taha, T. Y., Matsui, Y., Belinchón, F. J. Z., McCavitt-Malvido, M., Doruk, Y. U., et al. (2025) · eLife · doi:10.7554/elife.103484.2 · Cited by 2
Biomarker Development in Targeting Cancer Epigenetic
Cisarovsky, C., Benetkiewicz, M., Faivre, S. J., Raymond, É., & Gramont, A. D. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00005-9 · Cited by 1
Rueda, Y., Navarro-Imaz, H., Rekondo, I., Cristóbal, S., & Fresnedo, O. (2020) · EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria · doi:10.1387/ekaia.21405 · Cited by 1
Patel, S., Karlsson, M., Klahn, J. T., Gambino, F., Costa, H., McGuire, K. A., Baumgartner, C. K., Williams, J. P., Sandoz, S., & Kath, J. E. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.12.007 · Cited by 1
DORSSAA: Drug-Target interactOmics Resource Based on Stability/Solubility Alteration Assay
Zangene, E., Gholizadeh, E., Schwämmle, V., Saei, A. A., Wilhelm, M., Käll, L., & Jafari, M. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101603 · Cited by 3
“Recent innovations in solubility and stability alteration assays have revolutionized the study of drug-protein interactions (12, 13).”
Profiling of the Proteins Interacting with Amyloid Beta Peptides in Clinical Samples by PACTS-TPP
Xu, M., Wang, X., Zhang, Y., Ji, N., Wang, Q., Zhao, T., Zhou, C., & Jia, C. (2024) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.4c00083 · Cited by 2
Identification of the binding proteins of organic acid metabolites by matrix thermal shift assay
Li, K., Ye, Y., Zhang, X., Zhou, J., Li, Y.-N., & Ye, M. (2024) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2023.07002 · Cited by 1
Recent advances in protein precipitation-based methods for drug-target screening
Tong, L. I. U., Qin, W., & Yang, H. (2024) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2023.11019 · Cited by 1
Xue, L., van Kalken, D., James, E. M., Giammo, G., Labenski, M., Cantin, S. M., Fahnoe, K. C., Worm, K., Wang, Z., & Corin, A. F. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00326 · Cited by 1
Thermal Stress and Nuclear Transport
Kose, S., Ogawa, Y., & Imamoto, N. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4584-5_5 · Cited by 1
Ser, Z., & Sobota, R. M. (2024) · PROTEOMICS · doi:10.1002/pmic.202400147 · Cited by 1
“High throughput, quantitative mass spectrometry (MS) proteomics appeared as a compatible analytical method of choice to complement CETSA, aka Thermal Protein Profil-ingassay(TPP)[4–6].”
Thermal proteome profiling of protein-centric interactions and modifications
Chen, Z., Wang, A., & Geng, Y. (2025) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2025.02.002 · Cited by 1
Waich, S., Kreidl, K., Vodopiutz, J., Demir, A. M., Pollio, A. R., Dostál, V., Pfaller, K., Parlato, M., Cerf–Bensussan, N., Adam, R., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.185508 · Cited by 1
Krátký, J., Zajíčková, M., Taki, A. C., Michel, O., Matoušková, P., Vokřál, I., Štěrbová, K., Vosála, O., Lungerich, B., Kurz, T., et al. (2025) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2025.100599 · Cited by 1
“Published evidence (Savitski et al., 2014; Perrin et al., 2020; Mateus et al., 2022) demonstrates clearly the capacity of TPP in defining target molecules in biomedical projects such as cancer research.”
Emekeeva, D. D., Kusainova, T. T., Garibova, L. A., Шелепчиков, А. А., Kononikhin, A. S., Tretyakov, A. V., Лаврухина, О. И., Николаев, Е. Н., Gorshkov, M. V., & Tarasova, I. A. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297925600930 · Cited by 1
“…emergence of new areas of proteomic research, such as single-cell proteomics [41-45] and chemical proteomics based on thermal proteomic profiling [46, 47], as well as development of new technologies for ultrafast LC-MS analysis [7] provided a ground for a fresh look at possible approaches for…”
Kearly, A., & Nelson, A. D. L. (2025) · Journal of Experimental Botany · doi:10.1093/jxb/eraf240 · Cited by 2
Cao, X., Liu, W., Liu, L., Wang, S., Chen, P., & Cao, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152316 · Cited by 1
Targeting the unexplored 'dark proteome': Novel approaches in drug discovery
Singh, D. (2025) · Current Proteomics · doi:10.1016/j.curpro.2025.100020 · Cited by 2
Proteomic analysis related to the mechanism of high-altitude polycythemia in tibetans
Deji, C., Liu, S., Gong, X., Li, F., Silang, Q., Lamu, C., Shi, H., Guo, X., Tian, X., & Ciren, Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152717 · Cited by 1
Liu, X., Ji, W., Tao, Y., Gong, Y., Zhang, Q., Lin, R., Yang, Y., Wang, Y., Li, S., Zhang, Y., et al. (2025) · Analytica Chimica Acta · doi:10.1016/j.aca.2025.344720 · Cited by 1
Recent advances in antitumor indole-chalcone derivatives: a mini review
Liu, G., Han, Y., Wei, Y., Qian, P., Zhou, Y., & Zheng, M. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178499 · Cited by 1
Jiao, H., Cázarez‐Márquez, F., Rumanova, V. S., Wang, Y., Kalsbeek, A., Kramer, G., Guo, S., & Yi, C. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100978 · Cited by 2
“TPP is a powerful method for evaluating protein thermal stability and abundance, enabling the unbiased identification of direct and indirect drug targets (37, 38).”
Ernest-Hoar, G. F., Simmons, M. E., & Loucks, C. M. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0303 · Cited by 2
3D Proteomics: Structural, Functional, Chemical and Biomarker Discovery Proteomics With LiP-MS
Elsässer, F., de Souza, N., & Picotti, P. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101552 · Cited by 1
“Finally, TPP, although not strictly a structural proteomics approach, detects changes in thermal melting curves as a readout for altered protein stability, which includes changes due to altered protein structures (95–97).”
Top‐Down Mass Spectrometry–Based Structural and Functional Proteomics: A Perspective
Cupp‐Sutton, K. A., & Wu, S. (2026) · Journal of Mass Spectrometry · doi:10.1002/jms.70044 · Cited by 2
Li, J., Wang, Y., Ma, R., Zhang, G., Zhu, H., & Shi, J. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158270 · Cited by 1
Balıkçı, E., & Akıl, C. (2026) · Sensors · doi:10.3390/s26103105 · Cited by 2
“This allows simultaneous assessment of target engagement and off-target stabilization across large portions of the proteome [61,62].”
Kinetic control of macrophage death by PTM-turnover crosstalk in infection and inflammation
Saha, S., Verma, R., & Nita‐Lazar, A. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.04.011 · Cited by 2
Identification of drug repurposing candidates for the treatment of polycystic kidney disease
Meyer, A., Sotiropoulou, P., Bouker, K., Svedberg, D., Hammar, R., Bange, H., Larsson, P., Mateus, A., Dietrich, D. R., & Artursson, P. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70493 · Cited by 2
“Not all protein – ligand interactions result in measurable shifts in thermal stability (Savitski et al., 2014).”
Guo, Y., Chowdhury, T., Galie, W., Cupp‐Sutton, K. A., Zhao, Z., Solenberger, A., Yu, D., & Wu, S. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345846 · Cited by 1
Richards, D. M., Zhai, F., Li, S., & Yu, Q. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6c00125 · Cited by 1
Lyu, H., Gharibi, H., Sokolova, B., Varlı, M., Voiland, A., Nilsson, B., Meng, Z., Gaetani, M., Saei, A. A., & Zubarev, R. A. (2026) · Communications Chemistry · doi:10.1038/s42004-026-02207-z · Cited by 1
“From the previous similar efforts with drug target identi fi cation by expression proteomics 18 , we expected that the datasets for the drugs with the same target would be found to be co-localized in hierarchical clustering, revealing similar drug mechanisms.”
2014: Signaling Breakthroughs of the Year
Berndt, J. D., & Wong, W. (2015) · Science Signaling · doi:10.1126/scisignal.aaa4696 · Cited by 1
Leestemaker, Y., & Ovaa, H. (2015) · Nature Methods · doi:10.1038/nmeth.3660 · Cited by 1
Mapping paths: new approaches to dissect eukaryotic signaling circuitry
Mutlu, N., & Kumar, A. (2016) · F1000Research · doi:10.12688/f1000research.8818.1 · Cited by 1
A Step-Up LC-MS/MS for Proteomics
Wei, R. (2017) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2017.06.012 · Cited by 3
Target Validation—Prosecuting the Target
Jones, L. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00014-1 · Cited by 1
Zhao, R., Sa, X., Ouyang, N., Zhang, H., Yang, J., Pan, J., Jin-hui, G., & Zhou, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.723725 · Cited by 1
“Predicting lncRNA-mRNA-Drug Interactions for GBM In the drug discovery and repositioning process, computational prediction of drug-target interactions (DTIs) plays a key role in identifying putative new drugs or novel targets for existing drugs (Savitski et al., 2014; Chernobrovkin et al., 2015; Franken et al., 2015;…”
BackgroundIllustrative Tutorials for ProThermDB: Thermodynamic Database for Proteins and Mutants
Kulandaisamy, A., Nikam, R., Harini, K., Sharma, D., & Gromiha, M. M. (2021) · Current Protocols · doi:10.1002/cpz1.306 · Cited by 1
“Consequently, significant amounts of thermodynamic data are available in the literature (Durowoju, Bhandal, Hu, Carpick, & Kirkitadze, 2017; Greenfield, 2006; Liu & Fitzgerald, 2016; Savitski et al., 2014).”
BackgroundLabel-free LC-MS based assay to characterize small molecule compound binding to cells
Chen, M., Zhu, Z., Wisniewski, T., Zhang, X., McLaren, D. G., Weinglass, A. B., & Saldanha, S. A. (2022) · SLAS DISCOVERY · doi:10.1016/j.slasd.2022.08.005 · Cited by 1
Identifying drug targets with thermal proteome profiling using IBT‐16plex
Shi, Z., Ren, Y., Li, S., & Hao, P. (2023) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9673 · Cited by 1
Ultralight Ultrafast Enzymes**
Zhang, X., Meng, Z., Beusch, C. M., Gharibi, H., Cheng, Q., Lyu, H., Stéfano, L. D., Wang, J., Saei, A. A., Végvári, Á., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202316488 · Cited by 1
Deciphering protein interaction network dynamics with a machine learning-based framework
(2024) · Nature Methods · doi:10.1038/s41592-024-02180-2 · Cited by 1
Label-free Protein Analysis Methods for Active Compound Targets Identification
Lyu, B. J., Gou, W., Xu, F., Li, Y., Li, Y., & Hou, W. (2024) · 化学学报 · doi:10.6023/a24030082 · Cited by 1
Integrated Approach to Precision Oncology
Mohtar, M. A., Syafruddin, S. E., Abdullah‐Zawawi, M., Jalal, M. I. A., Low, T. Y., & Tan, S. C. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_450 · Cited by 1
Profiling the Misfolded Proteome in Human Disease
Onwudiwe, V. C., & Genereux, J. C. (2024) · Israel Journal of Chemistry · doi:10.1002/ijch.202300131 · Cited by 1
Mazur, M. T., Shyong, B., Huang, Q., Polsky-Fisher, S. L., Balibar, C. J., & Wang, W. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00563 · Cited by 1
Deng, L., Zhang, G., He, M. M., Wang, Y., Li, J., Xu, X., Hao, X., Fan, Y., & Mu, S. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117910 · Cited by 1
Proteome-scale studies of protein stability
Calloni, G., & Vabulas, R. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819132-3.00004-x · Cited by 1
Assays to Characterize the Cellular Pharmacology of a Chemical Probe
Stefaniak, J., Galan, S. R. G., & Huber, K. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00247 · Cited by 1
Sasidharan, S., Divakar, K., & Saudagar, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-8562-3_5 · Cited by 2
Marine Natural Products and Obesity
Urbatzka, R., & Vasconcelos, V. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-192-0 · Cited by 1
Zhang, Z., Zheng, M., Zhao, Y., & Wang, P. G. (2021) · Bioanalysis · doi:10.4155/bio-2021-0202 · Cited by 1
Chemical Approaches for Beta-cell Biology
Vetere, A., Parekh, V. S., Modell, A. E., Shoba, V. M., Choudhary, A., & Wagner, B. K. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00001 · Cited by 1
Luzarowski, M., & Skirycz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_8 · Cited by 1
Databases and Tools to Investigate Protein-Metabolite Interactions
de Souza, L. P., & Fernie, A. R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2624-5_14 · Cited by 1
Lavallée‐Adam, M., Pelletier, A. R., Diedrich, J. K., Low, W., Pinto, A. F. M., Martínez‐Bartolomé, S., Petrascheck, M., Moresco, J. J., & Yates, J. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/513663 · Cited by 1
“Four C. elegans untreated samples and two benomyl treated samples were each separated into 10 fractions using a thermal shift assay procedure slightly modified from the version presented by Savitski et al. 10 Lysates of C. elegans were prepared and incubated with benomyl, as described above, prior to the thermal shift…”
MethodInfluentialFunctional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1
Reznik, E., Christodoulou, D., Goldford, J. E., Briars, E. A., Sauer, U., Segrè, D., & Noor, Ε. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3155788 · Cited by 1
Bai, Y., Kim, J., Jayne, L. A., Gandhi, M., Huang, K. M., Silvaroli, J. A., Sander, V., Prosek, J. M., Jhaveri, K. D., Baker, S. D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.29.428783 · Cited by 1
Label‐Free Techniques for Target Discovery and Validation
Molina, D. M., & Dabrowski, M. A. (2019) · Methods and principles in medicinal chemistry · doi:10.1002/9783527818242.ch5 · Cited by 1
Self-citationNon-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinomaPreprint
Stein, B. D., Ferrarone, J. R., Gardner, E. E., Chang, J. W., Wu, D., Chen, Q., Hollstein, P. E., Yuan, M., Liang, R. J., Coukos, J. S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.01.462764 · Cited by 1
Neutron-activation analysis for measurement of concentration profiles in ion etching
Tartakovskii, V. M., & Vasil'ev, G. A. (1987) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · Cited by 1
A novel role of 3’,5’-cAMP in the regulation of actin cytoskeleton in ArabidopsisPreprint
Chodasiewicz, M., Figueroa, N. E., Franz, P., Luzarowski, M., Moreno, J. C., Childs, D., Masiuk, A., Saluja, M., Sampathkumar, A., Tsiavaliaris, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.31.478439 · Cited by 1
“This, however, cannot explain the change in actin interaction status measured by TPP.”
BackgroundMethodInfluentialYe, F. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch11 · Cited by 1
Jeckel, A. M., Beran, F., Züst, T., Younkin, G. C., Petschenka, G., Pokharel, P., Dreisbach, D., Ganal-Vonarburg, S. C., & Robert, C. A. M. (2022) · doi:10.31219/osf.io/kuszn · Cited by 1
Lizano-Fallas, V., del Amor, A. C., & Cristóbal, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.17.512512 · Cited by 1
A gene essentiality signature enables predicting the mechanism of action of drugsPreprint
Wang, W., Bao, J., Zheng, S., Huang, S., Aldahdooh, J., Wang, Y., Eriksson, J., Tanoli, Z., Zhang, X., Gaetani, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.07.514541 · Cited by 2
Metadata
- Authors
- Savitski, M. M., Reinhard, F. B. M., Franken, H., Werner, T., Savitski, M. F., Eberhard, D., Molina, D. M., Jafari, R., Dovega, R. B., Klaeger, S., Kuster, B., Nordlund, P., Bantscheff, M., & Drewes, G.
- Affiliations
- GlaxoSmithKline (Germany) (DE)
- Karolinska Institutet (SE)
- German Cancer Research Center (DE)
- Department of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, Freising, Germany.
- Division of Biophysics, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Corresponding author
- Savitski, Mikhail M.
- Reinhard, Friedrich B. M.
- Bantscheff, Marcus
- Drewes, Gerard
- ORCID
- Venue
- Science
- Published
- 2014-10-03
- Volume
- 346
- Issue
- 6205
- Pages
- 1255784-1255784
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2131321938
- Cited by
- 1,187
- References
- 41
- Citations by year
- 2026: 119 · 2025: 138 · 2024: 148 · 2023: 130 · 2022: 116 · 2021: 132 · 2020: 95 · 2019: 85 · 2018: 67 · 2017: 56 · 2016: 54 · 2015: 39 · 2014: 5
- FWCI
- 22.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › thermodynamics and calorimetric analyses
- Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
- Keywords
- thermal proteome profiling, drug-target engagement, protein thermal stability, kinase inhibitors, staurosporine, ferrochelatase, vemurafenib, alectinib, phototoxicity, dasatinib, BCR-ABL, cancer drug targets
- MeSH terms
- Adenosine Triphosphatases, Antineoplastic Agents, Hot Temperature, Humans, Ligands, Protein Binding, Protein Denaturation, K562 Cells, Proteome, Proteomics, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.